Financials

People

Activity

Newpath Management

Company

Investment-firm

Financing round

General

About Company
Newpath Partners is a life science venture firm that prioritizes excellent science and forming partnerships.

Industry

Sector :

Subsector :

Keywords :

Also Known As

Newpath Partners

founded date

15.08.2018

IPO status

Private

Description

The Boston-based private investment firm, established in 2018, focuses on aligning interests between academics, founders, and investors through trust and a shared vision. Led by an executive management team, Newpath Partners LP seeks to invest in innovative life science companies and provide them with the resources and support necessary to bring their products to market.
Contacts
Similar Companies
999
Masa Life Science Fund

Masa Life Science Fund

MASA Life Science Ventures is a venture capital firm that invests in early stage bio-technology and life science companies.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Location

Washington Cir NW, Washington, DC, USA

count Of Investments

4
Sofinnova Partners

Sofinnova Partners

Sofinnova Partners is a venture capital firm that invests in life sciences.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Location

Paris, France

total rounds

1

count Of Investments

287

count Of Exists

40
Hadean Ventures

Hadean Ventures

Hadean Ventures is a life science fund manager investing in companies across Europe, with a focus on the Nordic region.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Location

Oslo, Norway

total rounds

1

count Of Investments

22

count Of Exists

1
TVM Capital Life Science

TVM Capital Life Science

TVM Capital Life Science is a dedicated life science venture capital firm.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Venture Capital, Financial Services, Health Care

Location

Munich, Germany

count Of Investments

23

count Of Exists

2

Financials

Investments
18
Date 
name 
Lead 
type 
Raised 
18.04.2024
No
$290M
25.09.2023
Yes
$100M
Autobahn Therapeutics

Autobahn Therapeutics

Autobahn Therapeutics develops CNS therapies using human biology and brain-targeting chemistry.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Health Care, Biotechnology, Therapeutics

Location

San Diego, CA, USA

total rounds

3

total raised

$208.7M
Metsera

Metsera

Metsera operates as a clinical-stage biopharmaceutical company.

Location

New York, NY, USA

total rounds

2

total raised

$290M
Nvelop Therapeutics

Nvelop Therapeutics

Nvelop Therapeutics offers gene editing technology services for major diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care

total rounds

1

total raised

$100M
Co-Investors
Exits
1
Chroma Medicine

Chroma Medicine

Chroma Medicine revolutionizes treatment of genetic diseases with single-dose epigenetic medicines.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Genetics, Health Care

Location

Cambridge, MA, USA

total rounds

3

total raised

$260M

People

Founders
1
Thomas Cahill
Thomas Cahill

Thomas Cahill

Thomas Cahill is a Managing Partner of Newpath Partners.

current job

Newpath Management
Newpath Management

Thomas Cahill

Employee Profiles
3
Greg McGraw

Greg McGraw

Controller

Daniel Yadegar

Daniel Yadegar

CMO & Co-Founder

Thomas Cahill

Thomas Cahill

Co-Founder and Managing Partner

Activity

Recent News
0